534602-47-6 Usage
Description
1-N-Boc-3-Methylpiperidine-3-carboxylic acid is an organic compound that serves as a key intermediate in the synthesis of various pharmaceuticals. It is characterized by its Boc-protected piperidine structure and a carboxylic acid functional group, which makes it a versatile building block in the development of bioactive molecules.
Uses
Used in Pharmaceutical Industry:
1-N-Boc-3-Methylpiperidine-3-carboxylic acid is used as a reagent for the synthesis of tricyclic heterocyclic compounds. These compounds act as JAK1 inhibitors, which are valuable in the treatment of immunological and hyperproliferative disorders. By targeting the JAK1 pathway, these inhibitors can help regulate immune responses and control cell proliferation, offering potential therapeutic benefits for patients suffering from such conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 534602-47-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,4,6,0 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 534602-47:
(8*5)+(7*3)+(6*4)+(5*6)+(4*0)+(3*2)+(2*4)+(1*7)=136
136 % 10 = 6
So 534602-47-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H21NO4/c1-11(2,3)17-10(16)13-7-5-6-12(4,8-13)9(14)15/h5-8H2,1-4H3,(H,14,15)
534602-47-6Relevant articles and documents
PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYR-ROLO[2,3-D]PYRIDINYL ACRYLAMIDES
-
, (2015/06/17)
The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl and pyrrolo[2,3-d]pyridinyl acrylamides and analogues thereof. Such compounds are useful for inhibiting Janus Kinase (JAK). This invention also is directed to compositions comprising methods for making such compounds, and methods for treating and preventing conditions mediated by JAK.
Methods for inhibiting protein kinases
-
Page/Page column 158, (2010/11/26)
The present invention provides methods for inhibiting protein kinases selected from the group consisting of AKT, Checkpoint kinase, Aurora kinase, Pim kinases, and tyrosine kinase using pyrazolo[1,5-a]pyrimidine compounds and methods of treatment, prevent
